# US 2022/0273204 A1 · Intermittent Monitoring

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0273204 A1
- Document ID: US20220273204A1
- Status: Published application
- Kind: A1
- Application number: 17/743,786
- Filed: 2022-05-13
- Published: 2022-09-01
- Earliest claimed: 2018-12-19
- Assignees: DexCom, Inc.
- Applicants: Dexcom, Inc.
- Inventors: Apurv Ullas Kamath; Margaret A. Crawford; John Michael Gray; Hari Hampapuram; Matthew Lawrence Johnson; Subrai Girish Pai; Shawn Clay Sanders; Sumitaka Mikami
- Web page: https://patentgrep.com/patent/US20220273204A1

## CPC

- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/486: {Biofeedback (using electroencephalography [EEG] A61B5/375)}
- A61B 5/002: {Monitoring the patient using a local or closed circuit, e.g. in a room or building (A61B5/0017 takes precedence)}
- A61B 5/0022: {Monitoring a patient using a global network, e.g. telephone networks, internet}
- A61B 5/1118: {Determining activity level}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/1455: using optical sensors, e.g. spectral photometrical oximeters
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/7267: {involving training the classification device}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- A61B 5/7475: {User input or interface means, e.g. keyboard, pointing device, joystick}
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- G06F 11/1004: {to protect a block of data words, e.g. CRC or checksum (G06F11/1076 takes precedence; security arrangements for protecting computers or computer systems against unauthorized activity G06F21/00)}
- G16H 10/60: for patient-specific data, e.g. for electronic patient records
- G16H 40/67: for remote operation
- G16H 50/30: for calculating health indices; for individual health risk assessment
- A61B 5/0205: Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B 5/02438: {with portable devices, e.g. worn by the patient}
- A61B 2505/07: Home care
- A61B 2560/0209: adapted for power saving
- A61B 2560/0214: of power generation or supply
- G16H 20/17: delivered via infusion or injection
- G16H 40/20: for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Various examples are directed to systems and methods for measuring a parameter related to patient health. An analyte sensor system may detect that the analyte sensor system has been applied to a host and may store analyte data describing the host. The analyte sensor system may determine that sensor use at the analyte sensor system has terminated and upload stored analyte data to an upload computing device.

## Claims

### Claim 1

A computer-implemented method comprising:
receiving patient data for a patient, the patient data including glucose data of the patient collected by a glucose monitor;
determining, by a therapy selection model, suitable therapies which are suitable to control glucose of the patient based on the patient data;
filtering, by the therapy selection model, the suitable therapies to select a cost-effective therapy for the patient based at least in part on therapy cost data, the therapy cost data including costs of the suitable therapies; and
outputting a therapy recommendation to control glucose for the patient that includes the cost-effective therapy.

### Claim 2 (depends on 1)

The computer-implemented method of claim 1, wherein the patient data for the patient further includes a risk metric indicating a relative level of risk to the patient to experience an adverse health event based on the glucose data of the patient.

### Claim 3 (depends on 2)

The computer-implemented method of claim 2, wherein the therapy selection model selects the cost-effective therapy for the patient based at least in part on the risk metric of the patient.

### Claim 4 (depends on 1)

The computer-implemented method of claim 1, wherein the cost-effective therapy has a lowest cost of the suitable therapies which are suitable to control the glucose of the patient.

### Claim 5 (depends on 1)

The computer-implemented method of claim 1, wherein the therapy cost data further includes cost savings of the suitable therapies.

### Claim 6 (depends on 1)

The computer-implemented method of claim 1, wherein the suitable therapies include one or more of wearing a glucose monitor, automated coaching, insulin therapy using an insulin pen, or insulin therapy using an insulin pump.

### Claim 7 (depends on 1)

The computer-implemented method of claim 1, wherein the cost-effective therapy comprises insulin therapy using an insulin pen or an insulin pump.

### Claim 8 (depends on 1)

The computer-implemented method of claim 1, wherein the suitable therapies include insulin therapies using different types of insulin, each of the different types of insulin having a different cost.

### Claim 9 (depends on 8)

The computer-implemented method of claim 8, wherein the cost-effective therapy selected by the therapy selection model comprises an insulin therapy with a lowest cost.

### Claim 10

A system comprising:
a therapy selection model to:
receive patient data for a patient, the patient data including glucose data of the patient collected by a glucose monitor;
receive therapy selection data comprising available therapies and therapy cost data, the therapy cost data including costs of the available therapies; and
select a cost-effective therapy for the patient from the available therapies based on the glucose data of the patient and the therapy cost data; and
an output module to output the cost-effective therapy via a user interface.

### Claim 11 (depends on 10)

The system of claim 10, wherein the therapy selection model comprises a machine learning model.

### Claim 12 (depends on 10)

The system of claim 10, wherein the therapy selection model selects the cost-effective therapy based on the glucose data of the patient, the therapy cost data, and a risk metric of the patient, the risk metric indicating a relative level of risk to the patient to experience an adverse health event.

### Claim 13 (depends on 10)

The system of claim 10, wherein the therapy selection model selects the cost-effective therapy for the patient by:
determining suitable therapies which are suitable to control glucose of the patient based on the patient data; and
filtering the suitable therapies to select the cost-effective therapy for the patient based at least in part on the therapy cost data.

### Claim 14 (depends on 13)

The system of claim 13, wherein the cost-effective therapy has a lowest cost of the suitable therapies which are suitable to control the glucose of the patient.

### Claim 15 (depends on 13)

The system of claim 13, wherein the suitable therapies include insulin therapies using different types of insulin, each of the different types of insulin having a different cost.

### Claim 16 (depends on 15)

The system of claim 15, wherein the cost-effective therapy comprises an insulin therapy with a lowest cost.

### Claim 17 (depends on 10)

The system of claim 10, wherein the therapy cost data further includes cost savings of the available therapies.

### Claim 18 (depends on 10)

The system of claim 10, wherein the cost-effective therapy comprises one or more of wearing a glucose monitor, automated coaching, insulin therapy using an insulin pen, or insulin therapy using an insulin pump.

### Claim 19

A computer-implemented method comprising:
receiving patient data for a patient, the patient data including glucose data of the patient collected by a glucose monitor;
generating a risk metric for the patient based on the patient data, the risk metric indicating a relative level of risk of the patient experiencing an adverse health event;
determining, by a therapy selection model, suitable therapies which are suitable to control glucose of the patient based on the risk metric; and
outputting the suitable therapies via a user interface.

### Claim 20 (depends on 19)

The computer-implemented method of claim 19, wherein the risk metric is generated based at least in part on engagement by the patient with an automated coaching program.
